Kirby Institute

17 HIVreport 2 0

The latest instalment of Australia’s annual report card on HIV, hepatitis and sexually transmissible infections has been released this morning. Here’s what UNSW experts who work in these areas make of the results.

HIV treatment.jpg

Despite high-profile health campaigns and a concerted effort to make antiretroviral therapy more accessible, the number of new HIV cases in Australia has remained stable over the last three years, writes Bridget Haire.

10_png_child.jpg

The Kirby Institute at UNSW Australia will collaborate with the Papua New Guinea Institute of Medical Research and other national and international institutes to conduct a world-first study in maternal and newborn health in PNG.

Marlene Kong

Marlene Kong believes you need to experience disadvantage to really understand it. That’s why it’s time for more Indigenous-led medical research.

Same-sex marriage

The history of marriage and same-sex relationships spans millennia, but the political manifestation of same sex marriage is a strictly modern concept, writes Denton Callander.

28_methadone.jpg

Up to two million hepatitis C infections could be averted worldwide in the next ten years if opioid substitution therapy was more readily available to injecting drug users, a study from UNSW’s Kirby Institute has found.

16_scabies.jpg

The first ever international review of scabies and impetigo has indentified global hotspots and revealed children are disproportionately affected by the debilitating infectious conditions.

Dirty needle.jpg

The spread of HIV from injecting drug use in Australia has been contained, largely through the success of needle and syringe programs, according to a 20-year report released by the Kirby Institute at UNSW.

HIV treatment.jpg

An international study led by UNSW’s Kirby Institute has shown immediate treatment for people who are HIV positive can halve their risk of HIV-related serious disease or death.

HIVNegative 119653054 1

The Kirby Insitute at UNSW has launched a feasibility study to examine whether HIV negative people can take combination drug therapy to reduce their risk of acquiring the virus.

Pages